Suppr超能文献

第五版世界卫生组织与国际成熟 T 细胞淋巴瘤共识分类的比较。

A Comparison of the Fifth World Health Organization and the International Consensus Classifications of Mature T-Cell Lymphomas.

机构信息

Biobank of Research, IRCCS Azienda Opedaliera-Universitaria di Bologna, 40138 Bologna, Italy.

Department of Medical and Surgical Sciences, Bologna University School of Medicine, 40138 Bologna, Italy.

出版信息

Int J Mol Sci. 2023 Sep 16;24(18):14170. doi: 10.3390/ijms241814170.

Abstract

Peripheral T-cell lymphomas (PTCLs) are a rare subset of non-Hodgkin lymphomas that often carry significant difficulty in diagnosis and classification because of their rarity and biological complexity. Previous editions of the World Health Organization (WHO) classifications of hemopoietic neoplasms in 2001, 2008, and 2017 aimed to standardize hemopoietic neoplasm diagnosis in general. Since then, crucial clinico-pathological, immunophenotypic, and recent molecular discoveries have been made in the field of lymphomas, contributing to refining diagnostic criteria of several diseases, upgrading entities previously defined as provisional, and identifying new entities. In 2022, two different models were proposed to classify hematolymphoid neoplasms: the 5th edition of the WHO classification (WHO-HAEM5) and the International Consensus Classification (ICC). Of note, a common nosography is mandatory to ensure progress in health science and ensure the basis for a real precision medicine. In this article, the authors summarized the main differences with the previous fourth WHO edition and reviewed the main discrepancies between the two newest classifications, as far as PTCLs are concerned.

摘要

外周 T 细胞淋巴瘤(PTCLs)是一种罕见的非霍奇金淋巴瘤亚型,由于其罕见性和生物学复杂性,在诊断和分类方面常常存在很大的困难。2001 年、2008 年和 2017 年世界卫生组织(WHO)造血肿瘤分类的前几个版本旨在普遍标准化造血肿瘤的诊断。自那时以来,在淋巴瘤领域取得了关键的临床病理、免疫表型和最近的分子发现,有助于完善几种疾病的诊断标准,提升以前定义为临时的实体,并确定新的实体。2022 年,提出了两种不同的模型来对血液淋巴肿瘤进行分类:第五版世界卫生组织分类(WHO-HAEM5)和国际共识分类(ICC)。值得注意的是,为了确保健康科学的进步并为真正的精准医学奠定基础,强制性采用通用的分类学是必要的。本文作者总结了与前一版第四版 WHO 分类的主要区别,并就 PTCLs 而言,回顾了两个最新分类之间的主要差异。

相似文献

2
A comparison of the International Consensus and 5th World Health Organization classifications of mature B-cell lymphomas.
Leukemia. 2023 Jan;37(1):18-34. doi: 10.1038/s41375-022-01764-1. Epub 2022 Dec 2.
5
[Classification of peripheral T-cell lymphomas : News and open questions].
Pathologie (Heidelb). 2023 May;44(3):173-183. doi: 10.1007/s00292-023-01192-7. Epub 2023 Apr 28.
6
What is new in the classification of peripheral T cell lymphomas?
Pathologie (Heidelb). 2023 Dec;44(Suppl 3):128-135. doi: 10.1007/s00292-023-01260-y. Epub 2023 Dec 4.
7
Updates in the Classification of T-cell Lymphomas and Lymphoproliferative Disorders.
Curr Hematol Malig Rep. 2023 Dec;18(6):252-263. doi: 10.1007/s11899-023-00712-9. Epub 2023 Oct 23.
8
Update on the World Health Organization classification of peripheral T-cell lymphomas.
Curr Hematol Malig Rep. 2009 Oct;4(4):227-35. doi: 10.1007/s11899-009-0030-5.
9
[New classifications of malignant lymphomas - What changes are relevant for practice?].
Dtsch Med Wochenschr. 2024 May;149(11):613-620. doi: 10.1055/a-2160-5267. Epub 2024 May 15.
10
The 2022 classifications of lymphoid neoplasms : Keynote.
Pathologie (Heidelb). 2023 Dec;44(Suppl 3):121-127. doi: 10.1007/s00292-023-01247-9. Epub 2023 Nov 13.

引用本文的文献

1
Editorial: Rare hematological malignancies.
Front Cell Dev Biol. 2025 Apr 23;13:1600063. doi: 10.3389/fcell.2025.1600063. eCollection 2025.
2
Short histological kaleidoscope - recent findings in histology. Part IV.
Rom J Morphol Embryol. 2024 Jul-Sep;65(3):377-393. doi: 10.47162/RJME.65.3.01.
3
Histone Deacetylase Inhibitors for Peripheral T-Cell Lymphomas.
Cancers (Basel). 2024 Sep 30;16(19):3359. doi: 10.3390/cancers16193359.
4
Cutaneous Intravascular Hematolymphoid Entities: A Review.
Diagnostics (Basel). 2024 Mar 23;14(7):679. doi: 10.3390/diagnostics14070679.

本文引用的文献

1
Tyrosine kinases in nodal peripheral T-cell lymphomas.
Front Oncol. 2023 Feb 8;13:1099943. doi: 10.3389/fonc.2023.1099943. eCollection 2023.
4
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms.
Leukemia. 2022 Jul;36(7):1720-1748. doi: 10.1038/s41375-022-01620-2. Epub 2022 Jun 22.
6
Novel T Follicular Helper-like T-Cell Lymphoma Therapies: From Preclinical Evaluation to Clinical Reality.
Cancers (Basel). 2022 May 12;14(10):2392. doi: 10.3390/cancers14102392.
8
Detection of Gene Fusion Transcripts in Peripheral T-Cell Lymphoma Using a Multiplexed Targeted Sequencing Assay.
J Mol Diagn. 2021 Aug;23(8):929-940. doi: 10.1016/j.jmoldx.2021.04.013. Epub 2021 Jun 18.
9
Cutaneous T-cell lymphomas-An update 2021.
Hematol Oncol. 2021 Jun;39 Suppl 1:46-51. doi: 10.1002/hon.2850.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验